Aclaris Therapeutics shares owned by Blackstone Group
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Blackstone Group
from 13F filings
Historical chart of Blackstone Group investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by Blackstone Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $16k | 13k | 1.24 |
| 2023-12-31 | $14k | 13k | 1.05 |
| 2023-09-30 | $8.6M | 1.3M | 6.85 |
| 2023-06-30 | $135k | 13k | 10.37 |
| 2023-03-31 | $105k | 13k | 8.09 |
| 2022-12-31 | $205k | 13k | 15.75 |
| 2022-09-30 | $205k | 13k | 15.73 |
| 2022-06-30 | $182k | 13k | 13.96 |
| 2022-03-31 | $225k | 13k | 17.26 |
| 2021-12-31 | $189k | 13k | 14.50 |